Bio-Techne (TECH) Exchange Rate Effect (2009 - 2026)
Bio-Techne (TECH) posted quarterly Exchange Rate Effect of -$1.2 million for Q1 2026, down 9.9% year-over-year from -$1.3 million in Q1 2025, and down 387.65% quarter-over-quarter from $413000.0 in Q4 2025.
Powered by 
Analysis
Bio-Techne (TECH) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Bio-Techne's Exchange Rate Effect history runs 18 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 9.9% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at $11.4 million (up 195.56% YoY), while the FY2025 annual figure was $11.9 million, up 611.23% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$1.2 million, down from $413000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $13.4 million in Q2 2025, with the low at -$11.9 million in Q3 2022.
- The 5-year median for Exchange Rate Effect is -$1.1 million (2023), against an average of -$383176.5.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect slumped 4548.67% in 2022, then soared 569.18% in 2024.
- Bio-Techne's Exchange Rate Effect stood at $7.3 million in 2022, then tumbled by 53.4% to $3.4 million in 2023, then sank by 259.74% to -$5.5 million in 2024, then surged by 107.55% to $413000.0 in 2025, then sank by 387.65% to -$1.2 million in 2026.
- Business Quant data shows TECH's Exchange Rate Effect at -$1.2 million in Q1 2026, $413000.0 in Q4 2025, and -$1.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | -258,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -258,000.00 |
| Mar 31, 2026 | -1.19 Mn |
| Dec 31, 2025 | 413,000.00 |
| Sep 30, 2025 | -1.21 Mn |
| Jun 30, 2025 | 13.36 Mn |
| Mar 31, 2025 | -1.08 Mn |
| Dec 31, 2024 | -5.47 Mn |
| Sep 30, 2024 | 5.12 Mn |
| Jun 30, 2024 | 5.28 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | 3.42 Mn |
| Sep 30, 2023 | -8.69 Mn |
| Jun 30, 2023 | -1.13 Mn |
| Mar 31, 2023 | 2.32 Mn |
| Dec 31, 2022 | 7.35 Mn |
| Sep 30, 2022 | -11.90 Mn |
| Jun 30, 2022 | -6.67 Mn |
| Mar 31, 2022 | -4.09 Mn |
| Dec 31, 2021 | 3.08 Mn |
| Sep 30, 2021 | -4.40 Mn |